The Claim
In adults with atherogenic dyslipidemia, a 12-week hypocaloric carbohydrate-restricted diet (12% carbohydrate, 59% fat, 28% protein) results in greater reductions in fasting insulin (−50%) and glucose (−12%) and greater improvement in insulin sensitivity (−55%) compared to a hypocaloric low-fat diet (56% carbohydrate, 24% fat, 20% protein), indicating that carbohydrate restriction may be more effective for improving glycemic control in this population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For adults with a certain type of unhealthy cholesterol and blood sugar issues, cutting carbs way down for 12 weeks might lower insulin and blood sugar more than a low-fat diet — meaning it could help control blood sugar better.
See the scientific wording
In adults with atherogenic dyslipidemia, a 12-week hypocaloric carbohydrate-restricted diet (12% carbohydrate, 59% fat, 28% protein) leads to greater reductions in fasting insulin (−50%) and glucose (−12%) and greater improvement in insulin sensitivity (−55%) compared to a hypocaloric low-fat diet (56% carbohydrate, 24% fat, 20% protein), suggesting carbohydrate restriction may be more effective for improving glycemic control in this population.
What the research says
1 studyStudy: Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet
The study found that people with a certain type of cholesterol problem who ate fewer carbs had bigger drops in blood sugar and insulin than those who ate less fat, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.